ANTIVIRAL TREATMENT

The present description relates to the use of myramistin, its derivatives and the forms thereof for treating or ameliorating infections caused by enveloped viruses, methods for preparing the compounds and pharmaceutical compositions containing such compounds. In particular the use of myramistin, its...

Full description

Saved in:
Bibliographic Details
Main Authors BODE, Bram Peter Hilde, COURTENS, Charlotte, BERTON, Jan Karel Emiel Tuur, RUTTENS, Bart Antoon Judith, VAN AKEN, Koen Jeanne Alfons
Format Patent
LanguageEnglish
French
Published 10.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present description relates to the use of myramistin, its derivatives and the forms thereof for treating or ameliorating infections caused by enveloped viruses, methods for preparing the compounds and pharmaceutical compositions containing such compounds. In particular the use of myramistin, its derivatives and forms for treating or ameliorating infections caused by coronaviruses. More particularly, the present description relates to the use of myramistin, its derivatives and forms thereof for treating or ameliorating Coronavirus disease 2019 (COVID-19). La présente description concerne l'utilisation de myramistine, de ses dérivés et de formes associées pour le traitement ou le soulagement d'infections provoquées par des virus enveloppés, des procédés de préparation des composés et des compositions pharmaceutiques contenant de tels composés. En particulier, l'invention concerne l'utilisation de myramistine, de ses dérivés et de formes associées pour traiter ou améliorer des infections provoquées par des coronavirus. Plus particulièrement, la présente invention concerne l'utilisation de myramistine, de ses dérivés et de formes associées pour traiter ou soulager la maladie à Coronavirus 2019 (COVID-19).
Bibliography:Application Number: WO2021EP55504